Baird Medical Hosts Malaysian Thyroid Specialists for Advanced Microwave Ablation Training in China

Rhea-AI Summary

Baird Medical Investment Holdings (NASDAQ: BDMD) hosted a delegation of Malaysian thyroid specialists for advanced microwave ablation (MWA) training in China. The intensive clinical training and academic exchange took place at the Eighth Affiliated Hospital of Sun Yat-sen University and Shenzhen People's Hospital.

The comprehensive program included expert-led demonstrations, hands-on workshops, and live observation of MWA procedures. Participants engaged in discussions about procedural techniques, patient selection criteria, and post-treatment outcomes. According to Chairwoman Haimei Wu, these international exchanges play a important role in accelerating the global adoption of innovative thyroid treatment techniques.

Positive

• Expanding international presence through medical training initiatives
• Building strategic partnerships with Malaysian healthcare providers
• Advancing global adoption of company's microwave ablation technology

Negative

• None.

NEW YORK, April 24, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") proudly welcomed a delegation of leading thyroid specialists from Malaysia for an intensive clinical training and academic exchange at the Eighth Affiliated Hospital of Sun Yat-sen University and Shenzhen People's Hospital in Shenzhen, China.

The program underscores Baird Medical's commitment to promoting global collaboration and advancing clinical excellence in microwave ablation (MWA) for thyroid disease. Participating physicians engaged in an intensive, comprehensive curriculum that included expert-led demonstrations, hands-on workshops, and live observation of MWA procedures performed by leading specialists. These real-time clinical sessions enabled in-depth discussions regarding procedural technique, patient selection criteria, and post-treatment outcomes. The highly interactive format fostered meaningful knowledge exchange and reinforced international clinical partnerships.

"We were honored to host the esteemed doctors from Malaysia and witness their dedication to advancing minimally invasive care," said Haimei Wu, Chairwoman of Baird Medical. "These international exchanges are instrumental in accelerating the global adoption of innovative thyroid treatment techniques."

This successful event represents a significant step forward in Baird Medical's mission to expand global education and elevate clinical proficiency in microwave ablation. The Company remains dedicated to empowering healthcare professionals with the tools and expertise required to deliver safe, effective, and minimally invasive therapies for thyroid disorders.

About Baird Medical

Baird Medical is a forward-thinking medical device company specializing in minimally invasive diagnostics and treatment. It is dedicated to the research and development of surgical robotic systems and innovative minimally invasive surgical instruments. Our mission is to enhance patient outcomes through precision technology and advanced diagnostic solutions. The company will foster strategic collaborations with leading academic institutions. Our vision extends beyond surgical assistance, aiming to develop intelligent systems that proactively guide diagnostic decisions and preventive healthcare strategies. As an FDA 510(k)-certified medical device company, Baird Medical's solutions have been used in over 30 prestigious hospitals and clinics across the United States, including Johns Hopkins Hospital, Tulane Medical Center, Weill Cornell Medicine, and Columbia University Medical Center. Baird Medical is also the market leader in China in thyroid microwave ablation devices and consumables. Meanwhile, the company's minimally invasive treatment products are gradually expanding their commercial presence in over 20 countries worldwide.

Forward-Looking Statements

This press release includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or Baird Medical's future financial or operating performance. In some cases, you can identify forward-looking statements by terminology such as "may", "could", "should", "expect", "intend", "might", "will", "estimate", "anticipate", "believe", "budget", "forecast", "intend", "plan", "potential", "predict", "potential" or "continue", or the negatives of these terms or variations of them or similar terminology. Forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Baird Medical and its management, are inherently uncertain. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. You should not place undue reliance on forward-looking statements in this press release, which speak only as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein. Baird Medical does not undertake any duty to update these forward-looking statements.

Actual results may vary materially from those expressed or implied by forward-looking statements based on a number of factors, including, without limitation: (1) the risk that Baird Medical may not be successful in expanding its business in China or the United States; (2) changes in general economic conditions; (3) regulatory conditions and developments; (4) changes in applicable laws or regulations; (5) the nature, cost and outcome of pending and future litigation and other legal proceedings instituted against Baird Medical or others; and (5) other risks and uncertainties from time to time described in the Registration Statement relating to the Business Combination and the transition report, including those listed under the sections titled "Risk Factors" therein, and in ExcelFin's other filings with the SEC. 

The foregoing list of factors is not exclusive. Additional information concerning certain of these and other risk factors is contained in ExcelFin's most recent filings with the SEC and in the Registration Statement described above filed by Baird Medical in connection with its business combination with ExcelFin. All subsequent written and oral forward-looking statements concerning Baird Medical, the business combination described herein or other matters attributable to Baird Medical or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Baird Medical expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in their expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Contact:
Eric Huang, PR Liaison
Baird Medical Investment Holdings Ltd.
Phone: +1 (888) 508-6228
Email: ir@bairdmed.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-hosts-malaysian-thyroid-specialists-for-advanced-microwave-ablation-training-in-china-302435242.html

SOURCE BDMD

FAQ

What training program did Baird Medical (BDMD) host for Malaysian doctors in April 2025?

Baird Medical hosted an intensive clinical training and academic exchange program focused on microwave ablation (MWA) for thyroid treatment at two hospitals in Shenzhen, China.

What components were included in BDMD's microwave ablation training program?

The program included expert-led demonstrations, hands-on workshops, live procedure observations, and discussions about techniques, patient selection, and treatment outcomes.

Where did Baird Medical (BDMD) conduct its thyroid specialist training program?

The training was conducted at the Eighth Affiliated Hospital of Sun Yat-sen University and Shenzhen People's Hospital in Shenzhen, China.

What is the purpose of BDMD's international medical training initiatives?

The initiatives aim to promote global collaboration, advance clinical excellence in microwave ablation, and accelerate the global adoption of innovative thyroid treatment techniques.